In the News

Clinical ink Appoints Andrew Kraus as Chief Technology Officer

Clinical Ink, a global life science technology company, has announced the appointment of Andrew Kraus as chief technology officer. In this role, Kraus will lead the development of the company’s expanding technology portfolio to support clinical trials. Kraus is an accomplished global healthcare executive with a...

McKesson Ventures’ Dave Schulte Named One of Healthcare’s Top 25 Investors

McKesson Ventures Managing Director Dave Schulte has been recognized by GrowthCap as one of the top 25 healthcare investors for 2023. This award acknowledges healthcare investors who have demonstrated high levels of sustained investment performance and who are recognized as leaders by portfolio company CEOs,...

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trials in Sleep and Neurologic Disorders Using EEG Biomarkers

Koneksa has announced a partnership with Beacon Biosignals, a computational neurodiagnostics company, to launch a clinical trial to investigate the integration of Beacon’s at-home electroencephalogram (EEG) into the Koneksa Neuroscience Solution Toolkit. The Beacon platform unlocks longitudinal, at-home EEG technology, applies machine-learning algorithms to maximize...

Xealth Is Honored In 25th Anniversary Digital Health Awards®

McKesson Ventures portfolio company Xealth was selected as a winner in the 25th anniversary Digital Health Awards® program. This competition recognizes the best digital health resources. “Shaping Your Digital Health Future” received a Gold Award for Connected Digital Health: Consumer Directed Digital Health Programs. “Digital solutions are...

Real-Time Clinical Trial Monitoring at Clinical ink

Clinical Ink Senior Director Enterprise Architecture Alex Doan recently wrote a case study about how the company chose to use the Rockset analytics platform to improve query speed and other performance metrics. He began by explaining Clinical Ink, which he described as a suite of software...

McKesson Ventures’ Carrie Williams Speaks at 2023 DHIS Conference

[caption id="attachment_54085" align="alignright" width="400"] McKesson Ventures Vice President & Partner Carrie Williams spoke at the recent DHIS East Coast summit in Boston.[/caption] McKesson Ventures Vice President & Partner Carrie Williams spoke at the Digital Healthcare Innovation Summit, East Coast, which took place June 6 and 7,...

Inbound Health launches at-home post-surgery care

Inbound Health, a company that enables health systems and health plans to offer hospital-at-home and skilled-nursing-at-home programs, has announced that it is expanding its services to include general surgery, including orthopedics, bariatrics, and hernia. Inbound Health spun out of its parent company, Allina Health, in October...

‘A Startup Supporting Startups’: Inside Merck Digital Sciences Studio

Last year, McKesson Ventures joined Merck, Microsoft, the Global Health Innovation Fund, Northland Ventures, and the New Jersey Institute of Technology to create the Merck Digital Sciences Studio. The studio was inspired by the work of Geof Hannigan, a computational biologist at Merck. In his work,...